We are live on ! Find out more
BNR

Burning Rock Biotech
BNR

34 hedge funds and large institutions have $60.8M invested in Burning Rock Biotech in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

23% more capital invested

Capital invested by funds: $49.5M → $60.8M (+$11.3M)

0.05% less ownership

Funds ownership: 2.5% → 2.45% (-0.05%)

19% less funds holding

Funds holding: 42 → 34 (-8)

44% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 16

80% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 10

Holders
34
Holders Change
-8
Holders Change %
-19.05%
% of All Funds
0.54%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
2
Increased
9
Reduced
16
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KCM
Kynam Capital Management
New Jersey
+$1.88M
2
Millennium Management
Millennium Management
New York
+$1.59M
3
SSA
Schonfeld Strategic Advisors
New York
+$247K
4
PCM
Prelude Capital Management
New York
+$98.5K
5
RWMG
Redwood Wealth Management Group
New Jersey
+$40.2K

Top Sellers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
-$1.53M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$734K
3
Morgan Stanley
Morgan Stanley
New York
-$415K
4
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$328K
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$237K
Name Holding Trade Value Shares
Change 		Change in
Stake
EL
26
EWA LLC
Pennsylvania
$48.3K +$51.7K +1,725 New
CC
27
Cannell Capital
Wyoming
$45.6K – – –
XT
28
XTX Topco
Cayman Islands
$37.7K +$40.2K +1,343 New
Jane Street
29
Jane Street
New York
$29.2K -$142K -4,749 -82%
SAM
30
Storebrand Asset Management
Norway
$19K – – –
UBS Group
31
UBS Group
Switzerland
$8.19K +$3.15K +105 +56%
SNN
32
Shen Neil Nanpeng
$2.49K – – –
SOW
33
State of Wyoming
Wyoming
$568 -$30 -1 -5%
T. Rowe Price Associates
34
T. Rowe Price Associates
Maryland
– -$734K -32,636 Closed
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
– -$148K -6,593 Closed
Goldman Sachs
36
Goldman Sachs
New York
– -$125K -5,545 Closed
E
37
Ergoteles
New York
– -$112K -4,994 Closed
Manulife (Manufacturers Life Insurance)
38
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$84.4K -3,891 Closed
TD Asset Management
39
TD Asset Management
Ontario, Canada
– -$75.6K -3,359 Closed
HF
40
HRT Financial
New York
– -$53K -2,360 Closed
BFM
41
Boothbay Fund Management
New York
– -$44.8K -1,990 Closed
YIH
42
Y-Intercept (HK)
Hong Kong
– -$39K -1,732 Closed
TRCT
43
Tower Research Capital (TRC)
New York
– -$28K -1,237 Closed
1
2

BNR Hedge Fund Activity: Q1 2023 in Review

34 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q1 2023, worth a combined $60.8M — up 23% from $49.5M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of BNR and 2 opened new positions — a net loss of 8 holders — while 16 trimmed existing stakes and 9 added.

The largest buyer was Kynam Capital Management, adding an estimated $1.88M. The largest seller was Barclays, cutting an estimated $1.53M.

  • 34 institutional investors held Burning Rock Biotech (BNR) as of Q1 2023, down from 42 in Q4 2022.
  • Funds reported $60.8M of Burning Rock Biotech stock for Q1 2023, up 23% quarter-over-quarter.
  • 2 funds opened new Burning Rock Biotech positions in Q1 2023 and 10 closed out, a net change of -8 holders.
  • The largest Burning Rock Biotech buyer in Q1 2023 was Kynam Capital Management, an estimated $1.88M added.
  • The largest Burning Rock Biotech seller in Q1 2023 was Barclays, an estimated $1.53M sold.

Based on aggregated 13F filings for Q1 2023.